Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
Olaparib for the treatment of BRCA-mutated advanced ovarian cancer
Marklie Munroe, Jill Kolesar
Pharmacy Practice and Science
Internal Medicine
Markey Cancer Center / Cancer Research Priority Initiative
Obstetrics and Gynecology
Center for Computational Sciences
Materials Science Research Priority Initiative
Translational Oncology Research Program
Research output
:
Contribution to journal
›
Review article
›
peer-review
24
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Olaparib for the treatment of BRCA-mutated advanced ovarian cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Therapeutic Procedure
100%
Ovarian Cancer
100%
Olaparib
100%
Patient
41%
Gene
33%
Breast Cancer
33%
Platinum
25%
Clinical Trial
16%
DNA Repair
16%
Tumor Cell
16%
Fatigue
16%
Poly ADP Ribose Polymerase
16%
Diseases
8%
Malignant Neoplasm
8%
Association
8%
Protein
8%
Isoenzyme
8%
Adverse Event
8%
Genomic Instability
8%
Vomiting
8%
Cytochrome P450
8%
Progression Free Survival
8%
Anemia
8%
Diarrhea
8%
Cell DNA
8%
Lethality
8%
PARP Inhibitor
8%
Recurrent Ovarian Cancer
8%
Nausea
8%
Cell Death
8%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Olaparib
100%
Breast Cancer
33%
Platinum
25%
Clinical Trial
16%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
16%
Fatigue
16%
Neoplasm
16%
Cell Death
8%
Clinical Pharmacology
8%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
8%
Malignant Neoplasm
8%
Protein
8%
DNA
8%
Adverse Event
8%
Lethality
8%
Progression Free Survival
8%
Diarrhea
8%
Nausea
8%
Isoenzyme
8%
Cytochrome P450
8%
Vomiting
8%
Cell DNA
8%
Disease
8%
Anemia
8%